These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8542760)

  • 1. Cellular immunology of tetanus toxoid.
    Corradin G; Watts C
    Curr Top Microbiol Immunol; 1995; 195():77-87. PubMed ID: 8542760
    [No Abstract]   [Full Text] [Related]  

  • 2. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case.
    Saikh KU; Sesno J; Brandler P; Ulrich RG
    Vaccine; 1998; 16(9-10):1029-38. PubMed ID: 9682355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 1. Systems for the detection of in vitro synthetized specific immunoglobulins. Strategies of test development].
    Kiessig ST; Jahn S; Porstmann T; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):79-87. PubMed ID: 2959129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures].
    Jahn S; Kiessig ST; Grunow R; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):89-94. PubMed ID: 2959130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity against tetanus is often lacking in the elderly].
    Hof H; Bartel J
    Dtsch Med Wochenschr; 2011 Jan; 136(4):148-50. PubMed ID: 21246472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid assessment of tetanus vaccine-induced immunity in Bangladesh and the Gambia.
    Ramakrishnan G; Wright M; Alam M; Naylor C; Kabir M; Zerin A; Ferdous T; Pedersen K; Hennig BJ; Donowitz JR; Wegmuller R; Haque R; Petri WA; Herbein J; Gilchrist CA
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):272-274. PubMed ID: 27916543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of immunologic tolerance to tetanus toxoid by anti-human CD4 in HLA-DR3(+)/human CD4(+)/murine CD4(-) multiple transgenic mice.
    Laub R; Dorsch M; Wenk K; Emmrich F
    Transplant Proc; 2001 May; 33(3):2182-3. PubMed ID: 11377495
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro immunization for antibody production against tetanus toxin and toxoid. 3. Recombinant gamma interferon and indomethacin support specific antibody production induced by antigen-pulsed immobilized monocytes.
    Jahn S; Grunow R; Kiesing ST; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(4):239-44. PubMed ID: 2964178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced in vitro production of anti-tetanus toxoid antibody after repeated in vivo immunization with tetanus toxoid.
    Stevens RH; Saxon A
    J Immunol; 1979 Feb; 122(2):592-8. PubMed ID: 310845
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of the immunity against tetanus toxin following the use of a combined typhoid-tetanus vaccine.
    HEGYESSY G; BOZSOKY S; SCHULEK E
    Br J Exp Pathol; 1956 Jun; 37(3):300-5. PubMed ID: 13342355
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
    Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flocculation of tetanus toxin and toxoid. I.
    VAN RAMSHORST JD; RIJKS H
    Antonie Van Leeuwenhoek; 1954; 20(1):17-32. PubMed ID: 13159168
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
    Kodo H; Gale RP; Saxon A
    J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell hybridomas with tetanus-toxoid-specific helper activity.
    DeFreitas EC; Vella S; Linnenbach A; Croce CM; Koprowski H
    Curr Top Microbiol Immunol; 1982; 100():191-201. PubMed ID: 6807608
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures.
    North ME; Brenner MK
    Immunology; 1983 Jan; 48(1):157-63. PubMed ID: 6600229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
    Ponzio NM; Speirs RS
    Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
    Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of levels of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussis-tetanus vaccine.
    Matuhasi T; Ikegami H
    J Infect Dis; 1982 Aug; 146(2):290. PubMed ID: 7108275
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the problem of the mechanism of immunity to tetanus toxin early after active immunization].
    PEVNITSKII LA
    Biull Eksp Biol Med; 1959 Dec; 48():89-92. PubMed ID: 14432462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.